Hims Hers Health (NYSE: HIMS) — Perfil da empresa, notícias e dados financeiros
Hims & Hers Health is a telehealth company providing accessible primary care and mental health services online.
Hims Hers Health
Hims Hers Health is a telehealth and direct-to-consumer health platform operator based in the United States. The company provides a consumer-facing digital health interface connecting patients with licensed medical providers across specialties including sexual health, weight management, dermatology, mental health, and diagnostic lab testing. Through its telehealth platforms, patients complete virtual consultations, receive clinical recommendations, and obtain access to prescription medications, compounded pharmaceutical treatments, and over-the-counter health and wellness products. Prescribed medications and wellness products are delivered directly to consumers through affiliated pharmacy networks and fulfillment facilities, operating nationwide across all fifty states.
Resumo
Operações
Produtos e/ou serviços de Hims Hers Health
- Weight Management: Provision of telehealth access to licensed healthcare providers, weight-loss memberships, branded and compounded GLP-1 prescription medications, microdosing plans, digital tracking scales, and customized metabolic support programs designed for sustained weight reduction.
- Sexual Health: Online consultation services and direct delivery of prescription and non-prescription treatments addressing erectile dysfunction, premature ejaculation, low testosterone, and female sexual health conditions through compounded oral formulations, chewables, and daily regimen therapies.
- Hair Care and Dermatology: Telehealth clinical evaluations and distribution of personalized prescription products, including combined oral and topical minoxidil and finasteride treatments, alongside specialized over-the-counter hair growth shampoos, conditioners, and topical skin care solutions.
- Mental Health: Digital mental health care platform offering virtual evaluations by licensed medical professionals, continuous therapy options, and direct-to-home delivery of ongoing daily prescription psychiatric medications for managing common conditions like anxiety and depression.
- Diagnostic Labs and Biomarker Testing: Direct-to-consumer health diagnostic services enabling individuals to order at-home lab kits, test for more than 130 blood biomarkers, assess organ function and stress indicators, and receive doctor-developed actionable health plans.
- Primary Care and Daily Wellness: Virtual access to licensed healthcare practitioners for routine medical evaluations, preventive consultations, ongoing medical advice, and tailored wellness supplement regimens to support general long-term health and maintenance.
equipe executiva do Hims Hers Health
- Andrew DudumCo-Founder, Chairman & CEO
- Oluyemi OkupeCFO & Interim Chief Accounting Officer
- Mike ChiChief Operating Officer
- Mohamed ElShenawyChief Technology Officer
- Soleil Teubner BoughtonChief Legal Officer & Corporate Secretary
- Patrick CarrollGlobal Chief Medical Officer
- Deborah M. AutorChief Policy Officer & Director
- Peter StahlSenior Vice President of Men's Reproductive & Sexual Health
- Daniel LiebermanSenior Vice President of Mental Health
- Craig PrimackSenior Vice President of Weight Loss
Últimas notícias sobre a Hims Hers Health
Hims & Hers revenue accelerates 38% to $753.2 million
United StatesHims & Hers enters Japan with acquisition of telehealth firm Eucalyptus
United StatesHims & Hers revenue rises 4% to $608M, gross margins compress to 65%
United StatesHims & Hers shares surge as FDA schedules landmark peptide review
United StatesHims & Hers stock skyrockets on landmark Novo Nordisk deal
United StatesHims & Hers clinches $1.15B Eucalyptus deal for global push
United States
Principais indicadores financeiros
Resultados divulgados pela Hims Hers Health, em USD.
- Cap. de mercado
- 6,5 bi
- Receita (TTM)
- 2,6 bi
- P/L
- —
- LPA (diluído, TTM)
- -0.6
- Dividend yield
- —
- Margem de lucro
- -5.5%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 2,3 bi | 105,6 mi | 128,4 mi | |
| 1,5 bi | 61,9 mi | 126 mi | |
| 872 mi | -29,5 mi | -23,5 mi | |
| 526,9 mi | -68,7 mi | -65,7 mi |